Next Article in Journal
Crocus sativus L. Extracts and Its Constituents Crocins and Safranal; Potential Candidates for Schizophrenia Treatment?
Next Article in Special Issue
Cyclometalated Osmium Compounds and beyond: Synthesis, Properties, Applications
Previous Article in Journal
Correction: Simão, A.Y., et al. Evaluation of the Cytotoxicity of Ayahuasca Beverages. Molecules 2020, 25, 5594
Previous Article in Special Issue
New Bifunctional Bis(azairidacycle) with Axial Chirality via Double Cyclometalation of 2,2′-Bis(aminomethyl)-1,1′-binaphthyl
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 26
Issue 5
10.3390/molecules26051238
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Fluorescent Orthopalladated Complexes of 4-Aryliden-5(4H)-oxazolones from the Kaede Protein: Synthesis and Characterization

by
Eduardo Laga
1,
David Dalmau
1,
Sofía Arregui
1,
Olga Crespo
1,
Ana I. Jimenez
1,
Alexandra Pop
2,
Cristian Silvestru
2 and
Esteban P. Urriolabeitia
1,*
1
Instituto de Síntesis Química y Catálisis Homogénea (ISQCH), CSIC-Universidad de Zaragoza, Pedro Cerbuna 12, E-50009 Zaragoza, Spain
2
Supramolecular Organic and Organometallic Chemistry Centre, Departament of Chemistry, Faculty of Chemistry and Chemical Engineering, Babeş-Bolyai University, Str. Arany Janos 11, RO-400028 Cluj-Napoca, Romania
*
Author to whom correspondence should be addressed.
Molecules 2021, 26(5), 1238; https://doi.org/10.3390/molecules26051238
Submission received: 26 January 2021 / Revised: 22 February 2021 / Accepted: 22 February 2021 / Published: 25 February 2021
(This article belongs to the Special Issue Influencers in Organometallic Chemistry—A Themed Issue Honoring Dr. Michel Pfeffer)
Browse Figures
Versions Notes

Abstract

:
The goal of the work reported here was to amplify the fluorescent properties of 4-aryliden-5(4H)-oxazolones by suppression of the hula-twist non-radiative deactivation pathway. This aim was achieved by simultaneous bonding of a Pd center to the N atom of the heterocycle and the ortho carbon of the arylidene ring. Two different 4-((Z)-arylidene)-2-((E)-styryl)-5(4H)-oxazolones, the structures of which are closely related to the chromophore of the Kaede protein and substituted at the 2- and 4-positions of the arylidene ring (1a OMe; 1b F), were used as starting materials. Oxazolones 1a and 1b were reacted with Pd(OAc)2 to give the corresponding dinuclear orthometalated palladium derivates 2a and 2b by regioselective C–H activation of the ortho-position of the arylidene ring. Reaction of 2a (2b) with LiCl promoted the metathesis of the bridging carboxylate by chloride ligands to afford dinuclear 3a (3b). Mononuclear complexes containing the orthopalladated oxazolone and a variety of ancillary ligands (acetylacetonate (4a, 4b), hydroxyquinolinate (5a), aminoquinoline (6a), bipyridine (7a), phenanthroline (8a)) were prepared from 3a or 3b through metathesis of anionic ligands or substitution of neutral weakly bonded ligands. All species were fully characterized and the X-ray determination of the molecular structure of 7a was carried out. This structure has strongly distorted ligands due to intramolecular interactions. Fluorescence measurements showed an increase in the quantum yield (QY) by up to one order of magnitude on comparing the free oxazolone (QY < 1%) with the palladated oxazolone (QY = 12% for 6a). This fact shows that the coordination of the oxazolone to the palladium efficiently suppresses the hula-twist deactivation pathway.

1. Introduction

The synthesis of compounds with luminescent properties is currently one of the most active fields in chemical research, due to the applications of such materials in a variety of fields such as opto-electronic devices (cell phones, smart TVs, tablets and others), biological markers, sensors and many others [1,2,3,4,5,6,7]. Oxazolones and imidazolones are promising candidates for the preparation of compounds with remarkable luminescent properties and this is based on the fact that the chromophore of the green fluorescent protein (GFP) is a 4-arylidene-5(4H)-imidazolone (Figure 1a). The GFP is a protein of great importance because the expression of proteins bonded to the GFP allows fluorescent labeling inside cells. Due to these properties, the GFP is considered to be the microscope of the 21st century [8,9,10,11]. 4-Arylidene-5(4H)-oxazolones are closely related to imidazolones, which are precursors of the former (Figure 1b). Unsaturated oxazolones are also luminescent and they have additional remarkable photophysical properties that include two-photon absorption (TPA), up-conversion, nonlinear optical properties and unique behavior as molecular switches [12,13,14,15,16,17,18,19,20].
The luminescent properties of both unsaturated oxazolones and imidazolones are strongly dependent on the environment. When the imidazolone chromophore is removed from the confined space of the GFP, the quantum yield of the imidazolone drops by four orders of magnitude, thus evidencing the critical influence that the rigid environment has on the photophysical properties. Similarly, the quantum yields of oxazolones in solution are usually very low (10−2–10−4) and marked increases have been observed in solid state or at low temperature [21]. The reasons for this behavior have been studied in detail and it seems to be due to the presence of non-radiative decay channels, as an alternative to fluorescence, such as Z-E isomerization (amongst others). This isomerization can take place through different internal conversions: rotation around the C=C bond and/or a combination of the rotation around the C=C bond with rotation around the C–C bond, movement that is also called a hula-twist. There is an intense debate about the precise mechanism in action for each particular case, and research work is ongoing in this active area [22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45]. In other cases, the loss of fluorescence has been related to the energy gap between the stabilized excited state and the ground state [46].
Different approaches have been proposed to avoid the loss of fluorescence and these include the introduction of substituents at specific positions to promote self-restriction (Figure 2, left) or the establishment of intramolecular locks (Figure 2, middle and right) [47,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62]. Among these approaches, the most successful one is probably the introduction of a bridge between the ortho-position of the 4-arylidene ring and the N atom of the heterocycle. The use of either a hydrogen bond or a BF2 group provides an efficient lock of the internal motions and eliminates the non-radiative channels, with impressive increases in the fluorescence reported [47,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62].
Despite the outstanding results, other reports on the amplification of the luminescence by locking of oxazolones through ortho-functionalization have not been published. We recently described a contribution in this area in which palladium complexes were employed as an intramolecular lock, as shown in Figure 3 (left) [63]. The incorporation of the Pd(II) lock into the skeleton of (Z)-4-arylidene-2-phenyl-5(4H)-oxazolones and -imidazolones was achieved using C–H activation processes by methods developed by our group [64,65,66,67,68]. The acetylacetonate ligand was used as an ancillary group to complete the coordination sphere of the Pd center. The results showed that this type of Pd lock was effective and led to increases in the quantum yield (QY) of push–pull imidazolones by up to one order of magnitude [63]. With the aim of achieving additional tuning of the fluorescence by changing the ancillary ligands bonded to the palladium, several attempts were made to coordinate chelating ligands L^L other than acetylacetonate. However, all attempts to obtain more general structures were unsuccessful. It is likely that the steric hindrance resulting from the presence of the Ph ring in the 2-position of the heterocycle, which is in close proximity to the Pd-bonded L^L ligand, is the cause of this lack of reactivity. Therefore, only L^L ligands with low steric requirements (acac) were bonded to the Pd center to give stable complexes. In this respect, we previously observed markedly different behavior of C^N-chelating oxazolones with respect to other classical C^N chelates in the reactivity of such complexes towards bulky monodentate ligands such as phosphines [69].
In this publication, we present recent results obtained on using oxazolones 1a and 1b, which are related to the chromophore of the Kaede protein (Figure 3, right, and Scheme 1) [70,71,72]. Due to the presence of the (E)-styryl group in the 2-position of the heterocycle, this molecule is sterically less hindered than the 2-phenyl analog and the larger volume around the Pd center is expected to accommodate incoming ligands. In addition, the extended conjugation due to the 2-styryl fragment should red-shift the fluorescence, thus providing a wider range of emission wavelengths. The Kaede protein chromophore shows a much more intense fluorescence when compared with the GFP chromophore [70,71,72]. We selected OMe (1a) and F (1b) as 4-arylidene substituents for different reasons. On the one hand, the OMe group is strongly electron-donating and is expected to boost the charge transfer throughout the oxazolone (push–pull effect). On the other hand, it has been shown that F substituents promote additional red-shifts [59,60]. Furthermore, the substituents located at the 2- and 4-positions seem to maximize the charge transfer [46]. Overall, one would expect a less constrained orthopalladated moiety that is able to accommodate a wide range of auxiliary ligands while having a more conjugated system that is red-shifted and much more intense. The combination of a strongly emitting oxazolone ligand with the suppression of the hula-twist due to locking by orthopalladation should produce highly fluorescent systems. The results obtained on studying these systems are described below.

2. Results and Discussion

2.1. Synthesis, Characterization and Orthopalladation of Oxazolones 1a and 1b

The oxazolones 1a and 1b were prepared by the Erlenmeyer–Plöch method by reaction of N-cinnamoylglycine with the respective aldehyde (Scheme 1) [73,74,75,76,77,78,79]. The N-cinnamoylglycine was prepared by the Schotten–Baumann method [80].
Oxazolones 1a and 1b were characterized by mass spectrometry and NMR methods. The X-ray structure of 1a was also determined. The mass spectra of 1a and 1b confirmed the stoichiometry shown in Scheme 1. The 1H NMR spectra of 1a and 1b show the expected AMX spin systems for the C6H3 ring, as well as signals due to the styryl C(H)=C(H)C6H5 unit. The values of the 3JHH coupling constants (around 16.5 Hz) between the two olefinic protons are consistent with a trans arrangement of these protons and the E geometry for this C=C bond. The observation of the carbonyl carbon in the proton-coupled 13C NMR spectra as a doublet with a 3JCH coupling constant of 5.2 Hz shows that the exocyclic C(H)=C bond has the (Z) configuration [81]. The structure of 1a could be solved (Figure 4) but the data gathered were of poor quality. Therefore, a complete analysis of bond distances and angles could not be performed, and the structure was used only as a connectivity scheme. In any case, the determined structure and the solution NMR data are in full agreement.
In order to incorporate the Pd center into the oxazolone skeleton, the reactivity of 1a and 1b with Pd(OAc)2 (1:1 molar ratio) in CF3CO2H was evaluated by previously published methods [63,64,65,66,67,68]. In the case of the electron-rich oxazolone 1a, the reaction took place at room temperature to afford dimer 2a in good yield (94%) (see Scheme 2). The dinuclear nature of the product was confirmed by the mass spectrum of 2a. The orthopalladation was regioselective at the 6-position of the 4-arylidene ring, as inferred from the observation of an AB spin system (6.23 and 6.17 ppm, 4JHH = 2 Hz) in the 1H NMR spectrum of 2a, which corresponds to the C6H2 palladated ring. This selectivity is the same as that observed previously in related systems [63,64,65,66,67,68]. Additional signals due to the presence of the styryl moiety and the vinyl proton were also evident. The anti geometry of dimer 2a is suggested by the observation of a single peak for the CF3CO2 bridges in the 19F NMR spectrum. The data discussed above are consistent with the structure shown in Scheme 2 for 2a.
The reactivity of 1b towards Pd(OAc)2 (1:1 molar ratio) follows a slightly different pathway. The reaction requires reflux temperature for four hours in order to achieve full conversion. However, despite the complete consumption of 1b, the 1H and, more clearly, the 1H{19F} NMR spectra of 2b show that it is a mixture of four different orthopalladated complexes. In this respect, four different AB spin systems, quite similar to that observed for 2a, appear for 2b in the region 6.4–6.8 ppm, thus showing that the four complexes contain the C6H2 ring. Analysis of the 19F NMR spectrum of 2b also clearly shows the presence of four types of C6H2F2 rings in the molar ratio 1/0.6/0.4/0.3, together with signals assigned to the corresponding CF3CO2 ligands. The dinuclear (anti- and syn-) and trinuclear (also anti- and syn-) structures shown in Scheme 3 are in good agreement with the experimental findings. The formation of mixtures of dinuclear and trinuclear derivatives in F-substituted oxazolones has recently been described by us [67]. Trinuclear structures are not often found when dealing with orthopalladation processes, despite their relevance both in synthesis and catalysis [82,83]. In order to confirm the presence of species of different nuclearity, 1H DOSY experiments were carried out and the attenuation of the signals corresponding to the C6H2 fragment and those assigned to the olefinic proton was evaluated. The values obtained for the diffusion coefficient (D, m2s−1) are D = 1.00 × 10−9 and D = 9.12 × 10−10 m2s−1. The different D values show that the mixture is composed of complexes of different molecular sizes and, therefore, of different nuclearity, with the smaller D values associated with the larger trinuclear derivatives.
Further treatment of dinuclear 2a or the mixture 2b with excess LiCl in methanol at room temperature promoted the metathesis of the carboxylate bridges by chloride bridges to afford dinuclear derivative 3a (Scheme 2) or 3b (Scheme 5, see below). These types of chloride-bridged derivatives are generally good starting materials for the synthesis of other cyclometalated complexes containing a variety of ancillary ligands. The characterization of 3a and 3b could not be performed by NMR methods due to their lack of solubility, even in DMSO-d6. However, 3a and 3b gave elemental analysis results that were consistent with the proposed stoichiometries and bands were observed in the IR spectra assigned to the Pd–Cl stretch (see Materials and Methods and Supplementary Materials) [84].

2.2. Synthesis of Complexes with Orthopalladated Oxazolones and Different Ancillary Ligands

Attempts to study the photophysical properties of complexes 2a, 3a and 3b were unsuccessful. Complex 2a did not show emission, probably due to the flexibility of the carboxylate bridges, while 3a and 3b were completely insoluble in all organic solvents tested. As a consequence, it was decided to prepare mononuclear derivatives with different types of chelating ligands with the aim of increasing the solubility and the stability of the resulting bis-chelate derivatives, thus minimizing the deactivation pathways related to weakly bonded ligands. In addition, anionic and neutral chelating ligands with different donor atoms were selected in order to cover a wider range of structural situations and to study the influence that the global charge and the nature of the donor atoms have on the photophysical properties. Acetylacetonate and 8-hydroxyquinolinate were selected as O,O’- and N,O-anionic chelating groups, while 8-aminoquinoline, 2,2-bipyridine and 1,10-phenanthroline were representatives of N,N-neutral ligands. In all cases, the syntheses were performed following well-established procedures involving metathesis of anionic ligands or exchange of weakly coordinated neutral ligands, as shown in Scheme 4 and Scheme 5.
Treatment of 3a or 3b with Tl(acac) (1:2 molar ratio, acac = acetylacetonate) in CH2Cl2 at 25 °C gave the corresponding O,O’-acac derivatives 4a or 4b as deep orange solids, while reaction of 3a with 8-hydroxyquinoline in the presence of Ag2CO3 (1:2:2 molar ratio) afforded the red N,O-hydroxyquinolinate 5a. All complexes were obtained in good yields. Treatment of 3a with AgClO4 (1:2 molar ratio) in a mixture of CH2Cl2/acetone gave, after removal of the insoluble AgCl, a solution of the solvate [Pd(C,N-oxazolone)(acetone)x]ClO4. This solution was reacted with 8-aminoquinoline, 2,2-bipyridine or 1,10-phenanthroline (1:1 molar ratio) to afford the corresponding cationic derivatives [Pd(C,N-oxazolone)(N^N)]ClO4 (8-NH2quin 6a, bipy 7a, phen 8a) in good yields as bright red solids (Scheme 4).
The characterization of 4a–8a and 4b was carried out by HR mass spectrometry and NMR spectroscopy. Signals due to the orthopalladated oxazolones were clearly identified in the NMR spectra of all of the complexes. In the case of acac derivatives, additional peaks in the 1H NMR spectra of 4a and 4b were observed at around 5.5 (CH) and 1–2 ppm (CH3), and in the 13C NMR spectra at around 96 (CH), 187 (CO) and 27 ppm (CH3). These signals are due to the presence of the O,O’-chelated acac group. In the case of complexes 5a and 6a, two different geometric isomers were expected due to the presence of different donor atoms in the ancillary ligands. However, the 1H and 13C NMR spectra of each complex contained a single set of peaks, thus showing that they were obtained as single isomers. The assignment of all resonances was performed by COSY, HSQC and HMBC experiments. In addition, selective 1D-NOESY experiments on 6a (see Supplementary Materials) allowed the geometry of the obtained isomer to be determined. The inversion of the two protons of the orthopalladated C6H2 ring only showed clear NOE enhancements on the near OMe groups, so these experiments were inconclusive. However, inversion of the ortho proton of the pyridine ring resulted in a clear NOE effect on one of the olefinic protons of the styryl fragment, thus showing the proximity of the two moieties, as shown in Scheme 4. In turn, inversion of one of the olefinic protons promoted a strong NOE effect on the ortho proton of the pyridine ring as well as on the ortho protons of the Ph ring of the styryl unit. Characteristic peaks due to the presence of bipyridine and phenanthroline were also observed in the NMR spectra of 7a and 8a (SM).
The molecular structure of complex 7a was determined and this provided valuable information. A drawing of the cationic part of the complex is shown in Figure 5 and selected bond distances and angles are collected in Table 1. Crystallographic parameters concerning the data collection and structure solution are provided in the Experimental section and in the Supporting Information. In the complex, the Pd atom is in a slightly distorted square-planar environment (sum of angles around the Pd atom = 360.05°) and is bonded to the two N atoms of the bipy ligand, N1 and N2, to the N3 atom of the oxazolone heterocycle and to the ortho carbon C1 of the arylidene ring. Thus, orthopalladation of the chromophore of the Kaede protein leaves sufficient space to bond incoming ligands that are bigger than acetylacetonate, thus improving on previous results obtained with the chromophore of the GFP [63]. The Pd1–N2 bond distance [2.110(3) Å] is longer than the Pd1–N1 bond distance [2.060(3) Å] and this is due to the higher trans influence of the C1 atom trans to N2 with respect to the N3 atom trans to N1, although all Pd–N bond distances fall in the usual range of values found in the literature for this type of bond [85]. The Pd1–C1 bond distance [2.013(3) Å] is also typical for this type of bond [64,65,66,67,68].
However, beyond the immediate environment of the Pd atom (i.e., the four donor atoms), the complex has a structure that is very distorted (see Figure 6) with respect to the ideal flat geometry expected for highly conjugated ligands such as 2,2-bipyridine and the oxazolone. This distortion is a consequence of the strong intramolecular interactions between the bipy ligand and the oxazolone. This distortion can be envisaged by considering five different planes in the molecule and measuring the dihedral angles between them. Therefore, we define the following best least-squares planes: (1) the molecular plane containing the Pd1–C1–N3–N1–N2 atoms; (2) the 4-arylidene ring C1–C2–C3–C4–C5–C6; (3) the central part of the oxazolone C1–C6–C9–C10–N3; (4) the oxazolone ring and the styryl fragment C10–C20; (5) the bipy ligand N1–C25–C24–C26–N2–C27. Ideally, these five planes should be coplanar and the dihedral angles between them should be zero or close to zero. However, the values found experimentally are as follows: 1–2 = 40.76(3)°; 1–3 = 37.57(3)°; 1–4 = 50.30(3)°; 1–5 = 19.98(4)°; 2–3 = 19.89(3)°; 2–4 = 48.36(3)°; 2–5 = 27.16(4)°; 3–4 = 28.59(3)°; 3–5 = 17.79(4)°; 4–5 = 34.54(4)°. It is clear that the oxazolone shows a marked U-shaped distortion with the aim of minimizing intramolecular repulsions between the styryl fragment CH=CHPh and the pyridine ring N2–C26–C27–C28–C29–C30. In this way, the styryl fragment is on the upper side of the molecular plane (plane 1) while the oxazolone and the orthopalladated rings are in the lower part (Figure 6). The distortion is not particularly strong for the bipy rings.

2.3. Fluorescence Studies: Absorption and Excitation–Emission Spectra

The photophysical properties of the starting oxazolones (1a, 1b) and the orthopalladated complexes (4a, 4b, 6a, 7a) were measured in CH2Cl2 solution (concentration 5 × 10−4 M) at 25 °C. The two oxazolones 1a and 1b showed absorption maxima in the UV region of the spectrum (381–428 nm, Table 2 and SM), a transition corresponding to a π–π* charge transfer [14,15,16]. In the orthopalladated derivatives (4a, 4b, 6a, 7a), the maxima were red-shifted to the blue-green region (446–495 nm) with respect to the free oxazolones. This bathochromic shift has already been observed in oxazolones and imidazolones [63].
The measurement of the excitation–emission spectra of free oxazolones 1a and 1b showed that the excitation maxima were in the range 320–340 nm, as shown in Figure 7 and Table 3. The emission maxima corresponding to this excitation wavelength appeared at 505 and 462 nm, respectively. The two oxazolones showed similar weak emission intensities, as determined from the quantum yield measured for the fluorescence of 1a (< 1%). This low value is similar to values found in closely related push–pull oxazolones [63]. Therefore, the introduction of the styryl fragment in the 2-position of the oxazolone ring (Kaede chromophore) does not promote significant changes in the position of the absorption maxima, nor in the fluorescence intensity, with respect to those observed in the GFP-related chromophores.
With respect to the fluorescence of complexes 4a–8a and 4b, two main features were observed (see Table 3): (a) the expected red-shift of the emission maxima (range 525–599 nm) due to the incorporation of the metal into the oxazolone skeleton, as observed in the absorption spectra, and (b) a marked increase in the intensity of the fluorescence emission.
We observed differences in the shape and maxima position between the excitation and absorption spectra. Due to this fact, at this concentration, more diluted solutions (10−5 M and 10−6 M) of 6a were studied in detail (see SM). We observed that, upon dilution, the shape and maxima of absorption and excitation spectra fit better, suggesting aggregation effects at higher concentration.
The qualitative comparison of the fluorescence intensity (in counts) shows a general increase of two orders of magnitude from the free oxazolone 1a (around 2 × 104) to the orthometalated derivatives 4a–8a (around (1–5) × 106). A more rigorous comparison of QY (determined for 6a, the complex that shows the most intense emission) shows an increase of one order of magnitude, i.e., up to 12%. Therefore, the incorporation of the Pd atom into the oxazolone scaffold produced the expected increase in the fluorescence due to the suppression of non-radiative pathways. However, this increase was not observed in all cases because the intensity of the emission in the neutral complex 4b was very close to that observed for the free oxazolone 1b. Although the number of available examples is not large, the obtained data suggest that the presence of the Pd atom as an intramolecular lock, being necessary, is not sufficient, and that additional factors have to be considered. The presence of the Pd atom in the orthometalated oxazolones clearly modifies their electronic properties, such as the push–pull character. It is probable that the enhancement of the emissive behavior demands coordination to the metal, but such coordination should not diminish the D-π-A capability of the oxazolone fragment; rather, if possible, it should increase it. Therefore, these changes in the charge distribution promoted by the incorporation of the Pd could be responsible for the lack of fluorescence amplification from 1b to 4b, and even for the small changes in emission intensities observed along the set of complexes 4a–8a. Further studies aiming to establish the contribution of the steric and electronic factors to the increase in the fluorescence are currently being developed in our laboratories.

3. Materials and Methods

3.1. General Procedures

Solvents were obtained from commercial sources and were used without further purification. All reactions were performed without special precautions against air and moisture. C, H, N and S elemental microanalyses were carried out on a Perkin-Elmer 2400-B Series II Analyser. Electrospray ionization (ESI) mass spectra were recorded using a Bruker Esquire3000 plus™ ion-trap mass spectrometer equipped with a standard ESI source. High-resolution mass spectra-ESI (HRMS-ESI) were recorded using a Bruker MicroToF-Q™ system equipped with an API-ESI source and a Q-ToF mass analyzer, which allows a maximum error in the measurement of 5 ppm. Acetonitrile and methanol were used as solvents. For all types of MS measurements, samples were introduced in a continuous flow of 0.2 mL/min and nitrogen served both as the nebulizer gas and the dry gas. Infrared spectra were recorded on a Spectrum 100 Perkin-Elmer FTIR Spectrophotometer, with a universal attenuated total reflectance (UATR) accessory made from thallium bromide-iodide crystals (KRS-5), which allows the observation of the electromagnetic spectrum in the region between 4000 and 250 cm−1. The 1H, 13C{1H} and 19F NMR spectra were recorded on a Bruker Avance-300 spectrometer (δ in ppm; J in Hz). All experiments were recorded on solution at room temperature using CDCl3 as the deuterated solvent. Other conditions are specified for each particular case. The 1H and 13C{1H} spectra were referenced using the residual solvent signal as the internal standard, while 19F spectra were referenced to CFCl3. All of the experiments were carried out at 298 K (different conditions are indicated as appropriate). Assignment was performed, when necessary, with the help of the following 2D-NMR experiments: 1H-1H gradient-selected correlation spectroscopy (gCOSY), 1H-13C heteronuclear single quantum coherence (HSQC), 1H-13C heteronuclear multiple bond correlation (HMBC) and 1H-1H nuclear Overhauser enhancement spectroscopy (NOESY) experiments. Diffusion experiments (DOSY) of 2b were carried out on CDCl3 solution of an approximate 4 mM concentration at controlled temperature (300 K). The P30 (little delta) and D20 (big delta) values were optimized to achieve an almost complete attenuation of the signal for a value of the gradient (gpz6) of 90% of full power. Absorption spectra were measured on a Thermo Scientific Evolution 600BB spectrophotometer. The steady-state excitation–emission spectra were measured on a Jobin-Yvon Horiba Fluorolog FL-3-11 spectrofluorimeter. All measurements were carried out at room temperature on solutions of 5 × 10−4 M concentration using quartz cuvettes of 1 cm path length. The measurement of the quantum yield values (Φ) of 1a and 6a was carried out using the absolute method on a Quantaurus-QY C11347 spectrometer. Two different CH2Cl2 solutions of each compound (5 × 10−4 M) were measured in order to check data reproducibility. In addition, one solution of each compound was deoxygenated by passing argon through it, and the value of the QY was redetermined to check the influence of the O2 in the intensity of the luminescence. The oxazolones 1a and 1b were prepared using the Erlenmeyer–Plöchl method, by reaction of N-cinnamoylglycine with the corresponding aldehyde [74,75,76,77,78,79,80]. The N-cinnamoylglycine was prepared by the Schotten–Baumann method [81].

3.2. X-ray Crystallography

Single crystals of 1a and 7a of suitable quality for X-ray diffraction measurements were grown by slow diffusion of n-pentane into CH2Cl2 solutions of the crude product at –18 °C for one week. One selected single crystal of each compound was mounted at the end of a quartz fiber in a random orientation, covered with perfluorinated oil (magic oil) and placed under a cold stream of N2 gas. Crystallographic measurements were carried out at 100 K on a Bruker Smart APEX CCD diffractometer, using graphite-monochromated Mo Kα radiation (λ = 0.71073 Å). A hemisphere of data was collected in each case based on ω-scan or ϕ-scan runs. The diffraction frames were integrated using the program SAINT [86] and the integrated intensities were corrected for absorption with SADABS [87]. The structures were solved by direct methods with SHELXT-2014 [88]. All non-hydrogen atoms were refined with anisotropic displacement parameters. The hydrogen atoms were placed at idealized positions and treated as riding atoms. Each hydrogen atom was assigned an isotropic displacement parameter equal to 1.2–1.5 times the equivalent isotropic displacement parameter of its parent atom. For structure solving and refinement, the SHELXL-2016 [89] program in the WINGX Package was used [90]. The structures were refined to Fo2, and all reflections were used in the least-squares calculations. The structure of 1a could be solved, but the quality of the data was poor and the analysis of bond distances and angles could not be performed. As a consequence, this structure was used only as a connectivity scheme. CCDC-2035173 (7a) contains the supplementary crystallographic data. These data can be obtained free of charge from the Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif.

3.3. Synthesis and Characterization of Oxazolones 1a and 1b

3.3.1. Synthesis of 4-((Z)-2,4-Dimethoxybenzylidene)-2-((E)-Styryl)-5(4H)-Oxazolone (1a)

Sodium acetate (399.7 mg, 4.9 mmol) and 2,4-dimethoxybenzaldehyde (850.3 mg, 5.1 mmol) were added to a solution of N-cinnamoylglycine (1000.0 mg, 4.9 mmol) in acetic anhydride (10 mL). The suspension was heated under reflux (110 °C) for 3 h and then allowed to cool to room temperature. The solid formed upon cooling was treated with distilled water (30 mL) to give 1a as a deep orange solid, which was filtered off, washed with water (5 mL) and cold ethanol (10 mL) and dried under vacuum. Obtained: 509.1 mg (31% yield). HRMS (ESI+) [m/z]: calculated for C20H18NO4 336.1236 [M + H]+; found 336.1237. 1H NMR (CDCl3, 300.13 MHz): δ = 8.75 (d, J = 8.7 Hz, 1H, H6, C6H3), 7.77 (s, 1H, =CHvinyl), 7.62 (d, J = 16.2 Hz, 1H, =CHolef), 7.57 (m, 2H, Ho, C6H5), 7.44–7.40 (m, 3H, Hm, Hp, C6H5), 6.79 (d, J = 16.2 Hz, 1H, =CHolef), 6.63 (dd, J = 8.7, 1.8 Hz, 1H, H5, C6H3), 6.43 (d, J = 2.1 Hz, 1H, H3, C6H3), 3.88 (s, 6H, OCH3). 13C{1H} NMR (CDCl3, 75.47 MHz): δ = 167.82 (s, C=O), 164.10 (s, C–O, C6H3), 161.78 (s, C–O, C6H3), 161.06 (s, C=N), 142.31 (s, =CH, Colef), 134.85 (s, =C), 134.35 (s, CH, C6, C6H3), 130.49 (s, Ci, C6H5), 130.36 (s, CH, Cp, C6H5), 129.04 (s, CH, Co, C6H5), 127.97 (s, CH, Cm, C6H5), 125.75 (s, =CH, Cvinyl), 116.21 (s, C1, C6H3), 113.69 (s, =CH, Colef), 106.32 (s, CH, C5, C6H3), 97.68 (s, CH, C3, C6H3), 55.66 (s, OCH3), 55.55 (s, OCH3).

3.3.2. Synthesis of 4-((Z)-2,4-Difluorobenzylidene)-2-((E)-Styryl)-5(4H)-Oxazolone (1b)

The oxazolone 1b was prepared following the same experimental method as reported for 1a but using the corresponding aldehyde. Therefore, N-cinnamoylglycine (1000.0 mg, 4.9 mmol) was reacted with 2,4-difluorobenzaldehyde (0.56 mL, 5.1 mmol) and sodium acetate (399.7 mg, 4.9 mmol) in 10 mL of acetic anhydride under reflux (110 °C) for 3 h to give 1b as a yellow solid. Obtained: 426.6 mg (28% yield). HRMS (ESI+) [m/z]: calculated for C18H12F2NO2 312.0836 [M + H]+; found 312.0832. 1H NMR (300.13 MHz, CD2Cl2): δ = 8.89 (td, J = 8.7, 6.6 Hz, 1H, H6, C6H3F2), 7.80 (d, J = 16.2 Hz, 1H, =CHolef), 7.66 (m, 2H, Ho, C6H5), 7.49–7.47 (m, 3H, Hm, Hp, C6H5), 7.41 (s, 1H,=CHvinyl), 7.08 (td, J = 8.7, 2.4 Hz, 1H, H5, C6H3), 6.95 (ddd, J = 11.4, 9.0, 2.7 Hz, 1H, H3, C6H3), 6.87 (d, J = 16.2 Hz, 1H, =CHolef). 19F NMR (282.40 MHz, CD2Cl2): δ = –103.89 (quint, 1F, F-4, J = 8.5 Hz), –110.25 (quart, 1F, F-2, J = 8.5 Hz). 13C{1H} NMR (CD2Cl2, 75.47 MHz): δ = 166.62 (s, C=O), 164.49 (dd, 1JCF = 255.8 Hz, 3JCF = 12.1 Hz, C2–F, C6H3F2), 164.21 (s, C=N), 162.34 (dd, 1JCF = 258.9 Hz, 3JCF = 12.1 Hz, C4-F, C6H3F2), 144.40 (s, =CH, Colef), 134.49 (s, C, Ci, C6H5), 134.33 (d, 4JCF = 4.5 Hz, =C), 133.96 (dd, 3JCF = 9.8, 3JCF = 3.0 Hz, C6-H, C6H3F2), 130.92 (s, CH, Cp, C6H5), 129.09 (s, CH, Cm, C6H5), 128.22 (s, CH, Co, C6H5), 120.07 (dd, 3JCF = 6.8 Hz, 5JCF = 2.3 Hz, =CH, Cvinyl), 118.49 (dd, 3JCF = 11.3 Hz, 4JCF = 3.8 Hz, C1, C6H3F2), 113.10 (s, CH, =CH, Colef), 112.33 (dd, 2JCF = 21.1 Hz, 3JCF = 3.8 Hz, C5–H, C6H3F2), 103.99 (t, 2JCF = 25.6 Hz, C3–H, C6H3F2).

3.4. Synthesis and Characterization of the Orthopalladated Dimers with Trifluoroacetate Bridges 2a, 2b

3.4.1. Synthesis of Orthopalladated 2a

Pd(OAc)2 (137.2 mg, 0.6 mmol) was added to a solution of the oxazolone 1a (205.0 mg, 0.6 mmol) in trifluoroacetic acid (5 mL). The resulting suspension was stirred at room temperature for 40 min and distilled water (10 mL) was added. The resulting precipitate was filtered off, washed with distilled water (3 × 10 mL) until the characteristic smell of trifluoroacetic acid disappeared and dried under vacuum. Compound 2a was obtained as a red solid. Obtained: 316.2 mg (94% yield). HRMS (ESI+) [m/z]: calculated for C40H33N2O9Pd2 897.0256 [M–2CF3COO + OH]+; found: 896.9991. 1H NMR (CDCl3, 300.13 MHz): δ = 7.95 (s, 1H, Hvinyl), 7.56 (m, 2H, Ho, C6H5), 7.44–7.39 (m, 4H, Holef, Hm+Hpara, C6H5), 7.08 (d, J = 15.9 Hz, 1H, Holef), 6.23 (d, J = 1.8 Hz, 1H, H3, C6H2), 6.17 (d, J = 2.1 Hz, 1H, H5, C6H2), 3.94 (s, 3H, OCH3), 3.53 (s, 3H, OCH3). 13C{1H} NMR (CDCl3, 75.47 MHz): δ = 163.20 (s, C=N), 161.58 (s, C–O, C6H2), 160.46 (s, C=O), 158.82 (s, C–O, C6H2), 145.95 (s, =CH, Colef), 139.08 (s, =C), 134.01 (s, Ci, C6H5), 131.57 (s, CH, Cp, C6H5), 130.87 (s, =CH, Cvinyl), 129.04 (s, CH, Co, C6H5), 128.81 (s, CH, Cm, C6H5), 118.73 (s, C, C6H2), 115.36 (q, CF3, 1JCF = 287.5 Hz), 113.68 (s, C–Pd, C6H2), 110.69 (s, =CH, Colef), 108.97 (s, CH, C6H2), 96.66 (s, CH, C6H2), 55.86 (s, OCH3), 55.21 (s, OCH3). The signal due to the presence of the carboxylate carbon from the bridging CF3COO ligand was not found, despite the use of long accumulation times, probably due to the low solubility of this compound. 19F NMR (376 MHz, CDCl3): δ = −74.49 (s, CF3). IR (ν, cm−1): 1790 (C=O), 1662,1571 (O-C=N), 1642 (CF3COO bridging).

3.4.2. Reaction of Oxazolone 1b with Pd(OAc)2: Dinuclear and Trinuclear Derivatives (mixture 2b)

The oxazolone 1b (200.0 mg, 0.6 mmol) was reacted with Pd(OAc)2 (143.7 mg, 0.6 mmol) under reflux in trifluoroacetic acid (8 mL, 75 °C) for 4 h. After the reaction time, the mixture was allowed to cool to room temperature and water (20 mL) was added. Further stirring produced a yellowish-orange precipitate (2b). The solid was filtered off, washed with water (10 mL) and Et2O (10 mL) and dried under vacuum. Obtained: 312.8 mg. Product 2b was characterized by 1H, 1H{19F} and 19F NMR spectra as a mixture of four different compounds: two dinuclear (anti and syn) and two trinuclear (anti and syn). Only the major isomer (anti) of the dinuclear derivatives could be fully characterized by 13C NMR. 1H{19F} NMR (300.13 MHz, CD2Cl2): δ = 7.9–7.4 (m, =CHvinyl, =CHolef, C6H5, all isomers), 7.25 (d, J = 15.9 Hz, =CHolef), 7.23 (d, J = 15.9 Hz, =CHolef), 7.21 (d, J = 15.9 Hz, =CHolef), 7.09 (d, J = 15.9 Hz, =CHolef, dinuclear anti isomer, major isomer), 6.76, 6.68 (AB spin system, J = 2.4 Hz, C6H2F2 dinuclear anti isomer, major isomer), 6.71, 6.68 (AB spin system, J = 2.4 Hz, C6H2F2), 6.56, 6.47 (AB spin system, J = 2.4 Hz, C6H2F2). 19F NMR (282.4 MHz, CD2Cl2): δ = −75.07 (s, 3F, CF3), −101.02 (q, J = 9 Hz, 1F, C6H2F2), −108.68 (d, J = 6 Hz, 1F, C6H2F2) (dinuclear anti isomer, major isomer); −74.68, −74.69 (2s, 2CF3), −101.24 (q, J = 9 Hz, C6H2F2), −109.43 (d, J = 6 Hz, C6H2F2); −74.20, −74.43 (2s, 2CF3), −102.28 (q, J = 9 Hz, C6H2F2), −110.28, −110.49 (m, C6H2F2); −74.44, −74.45 (2s, 2CF3), −102.44 (q, J = 9 Hz, C6H2F2), −110.28 to −110.49 (d, J = 6 Hz, C6H2F2) (dinuclear and trinuclear minor isomers). 13C{1H} NMR (75.47 MHz, CD2Cl2): δ = 166.72 (s, C=N), 166.43 (s, C=O), 166.22 (q, 2J = 40.7 Hz, CO2CF3), 160.67 (dd, 1J = 235.02 Hz, 3J = 12.58 Hz, C2–F, C6H2F2), 159.36 (dd, 1J = 265.11 Hz, 3J = 13.32 Hz, C4-F, C6H2F2), 150.00 (s, =CHolef), 136.22 (br, =C), 136.09 (br, Pd–C6, C6H2F2), 133.49 (s, Ci, C6H5), 132.68 (s, Cp, CH, C6H5), 129.44 (s, Cm, CH, C6H5), 129.18 (s, Co, CH, C6H5), 126.00 (d, J = 6.0 Hz, =CHvinyl), 116.25 (dd, 2JCF = 21.9 Hz, 4JCF = 3.0 Hz, C5H, C6H2F2), 115.33 (br, C1, C6H2F2), 109.66 (s, =CH, Colef), 101.63 (t, 2JCF = 25.6 Hz, C3H, C6H2). The signal due to the CF3 carbon was not observed. IR (ν, cm−1): 1789 (C=O), 1651, 1572(O-C=N), 1605 (CF3COO bridging).

3.5. Synthesis and Characterization of the Orthopalladated Dimers with Chloride Bridges 3a, 3b

3.5.1. Synthesis of Orthopalladated 3a

An excess of anhydrous LiCl (30.6 mg, 0.7 mmol) was added to a solution of 2a (200.0 mg, 0.2 mmol) in methanol (15 mL), and the resulting mixture was stirred at room temperature for 2 h. During this time, a deep red solid precipitated. The solid (3a) was filtered off, washed with methanol (10 mL) and Et2O (20 mL) and dried under vacuum. Obtained: 126.5 mg (74% yield). Compound 3a was insoluble in the usual NMR solvents, thus precluding its routine characterization in solution even in the presence of pyridine-d5. Elemental analysis calculated for C40H32Cl2N2O8Pd2: C, 50.44; H, 3.39; N, 2.94; found: C, 50.13; H, 3.44; N, 3.08. IR (ν, cm−1): 1775 (C=O), 1637, 1560 (O–C=N), 314 (Pd–Cl).

3.5.2. Synthesis of Orthopalladated 3b

Complex 3b was prepared following the same experimental procedure as for 3a. Compound 2b (200.0 mg) was reacted with LiCl (32.2 mg, 0.8 mmol) in methanol (8 mL) at room temperature to give 3b as an orange solid. Obtained: 138.0 mg, (79% yield). Compound 3a was insoluble in the usual NMR solvents, thus precluding its routine characterization in solution even in the presence of pyridine-d5. Elemental analysis calculated for C36H20Cl2F4N2O4Pd2: C, 47.82; H, 2.23; N, 3.10; found: C, 47.47; H, 2.44; N, 2.99. IR (ν, cm−1): 1820, 1798 (C=O), 1654, 1591 (O–C=N), 318 (Pd–Cl).

3.6. Synthesis and Characterization of Orthopalladated Complexes with Acetylacetonate 4a and 4b

3.6.1. Synthesis of Orthopalladated 4a

Tlacac (63.7 mg, 0.2 mmol) was added to a stirred suspension of 3a (100.0 mg, 0.1 mmol) in CH2Cl2 (10 mL). The appearance of the suspension changed in a few minutes and a red solution with a gray solid in suspension was obtained. The mixture was stirred at room temperature for 20 min and then filtered over a Celite pad. The Celite was washed with CH2Cl2 (10 mL). The clear red solution was evaporated to dryness and the solid residue was treated with cold n-pentane (20 mL). The resulting orange solid was filtered off, washed with n-pentane (2 × 5 mL), dried under vacuum and characterized as 4a. Obtained: 100.0 mg (88% yield). HRMS (ESI+) [m/z]: calculated for C21H20NO5Pd 472.0376 [M–acac + CH3OH]+; found 472.0396. 1H NMR (300.13 MHz, CDCl3): δ = 8.13 (s, 1H, =CHvinyl), 7.67 (d, J = 16 Hz, 1H, =CHolef), 7.60–7.52 (m, 3H, Ho, C6H5, =CHolef), 7.44–7.42 (m, 3H, Hm, Hp, C6H5), 7.04 (d, J = 2.4 Hz, 1H, C6H2, H5), 6.18 (d, J = 2.4 Hz, 1H, C6H2, H3), 5.45 (s, 1H, CH, acac), 3.90 (s, 3H, OCH3), 3.85 (s, 3H, OCH3), 2.08 (s, 3H, CH3, acac), 1.94 (s, 3H, CH3, acac). 13C{1H} NMR (75.47 MHz, CDCl3): δ = 187.64 (s, C–O, acac), 186.80 (s, C–O, acac), 162.86 (s, C2–O, C6H2), 162.41 (s, C=N), 162.23 (s, C4–O, C6H2), 160.14 (s, C=O), 150.10 (s, =C), 143.75 (s, =CH, Colef), 135.02 (s, Ci, C6H5), 133.17 (s, =CH, Cvinyl), 130.99 (s, CH, Cp, C6H5), 129.25 (s, CH, Co, C6H5), 128.47 (s, Cm, C6H5), 119.58 (s, C1, C6H2), 116.35 (s, C6–Pd, C6H2), 113.13 (s, =CH, Colef), 111.07 (s, C5H, C6H2), 100.34 (s, CH, acac), 95.80 (s, C3H, C6H2), 55.83 (s, OCH3), 55.57 (s, OCH3), 27.87 (s, CH3, acac), 27.76 (s, CH3, acac).

3.6.2. Synthesis of Orthopalladated 4b

Complex 4b was obtained following the same experimental procedure as described for 4a. Compound 3b (100.0 mg, 0.1 mmol) was reacted with Tlacac (70.5 mg, 0.2 mmol) in CH2Cl2 (10 mL) to give 4b as an orange solid. Obtained: 90.2 mg (79% yield). HRMS (ESI+) [m/z]: calculated for C19H14F2NO3Pd 447.9977 [M–acac + CH3OH]+; found 447.9972. 1H NMR (300.13 MHz, CDCl3): δ = 7.83 (s, 1H, =CHvinyl), 7.76 (d, J = 16.2 Hz, 1H, =CHolef), 7.61–7.55 (m, 3H, Ho, C6H5, =CHolef), 7.46–7.40 (m, 3H, Hm, Hp, C6H5), 7.38 (dm, J = 9.6 Hz, 1H, C6H2F2, H5), 6.61 (ddd, J = 10.5, 8.4, 2.4 Hz, C6H2F2, H3), 5.47 (s, 1H, CH, acac), 2.12, 1.94 (2s, 2CH3, acac). 19F{1H} NMR (282.4 MHz, CDCl3): δ = −101.99 (d, J = 8.5 Hz, 1F), −111.07 (d, J = 11.3 Hz, 1F). 13C{1H} NMR (75.47 MHz, CDCl3): δ = 187.49 (s, C–O, acac), 187.21 (s, C–O, acac), 165.53 (s, C=N), 161.32 (s, C=O), 146.58 (s, =CH, Colef), 134.57 (s, Ci, C6H5) 131.79 (s, Cp, C6H5), 129.40 (s, Co, C6H5), 129.04 (d, 3JCF = 6.0 Hz, =CH, Cvinyl), 128.90 (s, Cm, C6H5), 117.07 (d, 2JCF = 16.6 Hz, C5H, C6H2F2), 112.68 (s, =CH, Colef), 100.62 (s, CH, acac), 100.61 (d, 2JCF = 52.82 Hz, C3H, C6H2), 27.76 (s, CH3, acac), 27.71 (s, CH3, acac). Signals due to the =C carbon of the oxazolone ring and the quaternary C atoms of the C6H2F2 ring (C1, C2–F, C4–F and C6–Pd) were not observed due to the low solubility of this compound.

3.7. Synthesis and Characterization of Orthopalladated Complex with 8-Hydroxyquinolinate 5a

8-Hydroxyquinoline (30.5 mg, 0.2 mmol) and Ag2CO3 (57.9 mg, 0.2 mmol) were added to a suspension of 3a (100.0 mg, 0.1 mmol) in a mixture of CH2Cl2 and acetone (8:2, 20 mL), protected from light. The mixture was stirred at room temperature for 16 h and filtered through a pad of Celite. The Celite was washed with CH2Cl2 (2 × 10 mL) and the clear red solution was evaporated to dryness. The residue was treated with cold Et2O (25 mL) and stirred. The resulting suspended red solid was filtered off, washed with Et2O (10 mL), dried under vacuum and identified as 5a. Obtained: 111.2 mg (91% yield). HRMS (ESI+) [m/z]: calculated for C29H23N2O5Pd 585.0642 [M + H]+; found 585.0656. 1H NMR (300.13 MHz, CD2Cl2): δ = 8.62 (d, J = 5.1 Hz, 1H, H1′, C9H6NO), 8.54 (d, J = 8.1 Hz, 1H, H3′, C9H6NO), 8.02 (s, 1H, =CHvinyl), 7.78 (dd, J = 7.5, 5.1 Hz, 1H, H2′, C9H6NO), 7.47–7.36 (m, 6H, H7′, H6′, H5’, C9H6NO, =CHolef, Ho C6H5), 7.16–7.04 (m, 3H, Hm, Hp, C6H5), 7.06 (d, J = 16 Hz, 1H, =CHolef), 6.45, 6.42 (AB spin system, J = 1.8 Hz, 2H, C6H2, H3, H5), 4.11 (s, 3H, OCH3), 3.92 (s, 3H, OCH3). 13C{1H} NMR (75.47 MHz, CD2Cl2): δ = 149.35 (s, CH, C1′, C9H6NO), 140.73 (s, CH, C3′, C9H6NO), 132.28 (s, =CH, Cvinyl), 132.14 (s, =CH, Colef), 130.67 (s, Cp, C6H5), 129.56 (2C overlapped, CH, C6′, C7′, C9H6NO), 129.05 (s, Co, C6H5), 128.61 (s, =CH, Colef), 128.33 (s, CH, C5′, C9H6NO), 128.14 (s, Cm, C6H5), 123.00 (s, CH, C2′, C9H6NO), 118.83 (s, CH, C6H2), 95.32 (s, CH, C6H2), 56.48 (s, OCH3), 55.98 (s, OCH3.). The low solubility of this compound, even in CD2Cl2, only allowed the CH nuclei to be detected properly, thus precluding the observation of signals due to quaternary C nuclei even in HMBC correlations.

3.8. Synthesis and Characterization of Orthopalladated Complex with 8-Aminoquinoline 6a

AgClO4 (45.7 mg, 0.2 mmol) was added to a suspension of 3a (100 mg, 0.1 mmol) in a mixture of CH2Cl2 and acetone (9:1, 10 mL), protected from light. The resulting suspension was stirred at room temperature for 1 h and filtered over a Celite pad in order to remove the AgCl. The Celite pad was washed with additional CH2Cl2 (10 mL). The clear filtered solution of the solvate was treated with 8-aminoquinoline (31.7 mg, 0.2 mmol) and stirring was maintained at room temperature for 1 h. The resulting solution was evaporated to dryness and the residue was treated with Et2O (20 mL). Upon further stirring, a red solid (6a) precipitated, and this was filtered off, washed with ether (20 mL) and dried under vacuum. Obtained: 136.9 mg (97% yield). HRMS (ESI+) [m/z]: calculated for C29H24N3O4Pd 584.0802 [M–ClO4]+; found 584.0793. 1H NMR (300.13 MHz, CD2Cl2): δ = 8.54 (dd, J = 5.1, 1.2 Hz, 1H, H1′, C9H8N2), 8.46 (dd, J = 8.4, 1.5 Hz, 1H, H3′, C9H8N2), 8.20 (d, J = 7.2 Hz, 1H, H7′, C9H8N2), 8.11 (s, 1H, =CHvinyl), 8.01 (d, J = 16 Hz, 1H, =CHolef), 7.95 (d, J = 8 Hz, 1H, H5′, C9H8N2), 7.78 (t, 1H, H6′, C9H8N2), 7.57 (m, 2H, Ho, C6H5), 7.48 (dd, J = 8.4, 5.1 Hz, 1H, H2′, C9H8N2), 7.46–7.32 (m, 3H, Hm, Hp, C6H5), 7.11 (d, J = 16.2 Hz, 1H, =CHolef), 6.83 (d, J = 1.8 Hz, 1H, H5, C6H2), 6.31 (d, J = 2.1 Hz, 1H, H3, C6H2), 4.08 (s, 3H, OCH3), 3.93 (s, 3H, OCH3). 13C{1H} NMR (75.47 MHz, CD2Cl2): δ = 164.07 (s, C2–O, C6H2), 161.71 (s, C4–O, C6H2), 161.59 (s, C=N), 161.09 (s, C=O), 149.78 (s, CH, C1′, C9H8N2), 148.57 (s, =C), 146.83 (s, =CH, Colef), 146.23 (s, C, C4′, C9H8N2), 139.64 (s, CH, C3′, C9H8N2), 137.21 (s, C, C8′, C9H8N2), 134.40 (s, =CH, Cvinyl), 133.76 (s, C1, C6H2), 131.95 (s, CH, Cp, C6H5), 129.98 (s, Ci, C6H5), 129.28 (s, Cm, C6H5), 129.04 (s, CH, C7′, C9H8N2), 128.86 (s, Co, C6H5), 128.53 (s, CH, C5′, C9H8N2), 127.66 (s, CH, C6′, C9H8N2), 122.16 (s, CH, C2′, C9H8N2), 119.06 (s, C, C9′, C9H8N2), 117.06 (s, C6-Pd, C6H2), 113.78 (s, C5H, C6H2), 110.69 (s, =CH, Colef), 96.25 (s, C3H, C6H2), 56.57 (s, OCH3), 55.93 (s, OCH3).

3.9. Synthesis and Characterization of Orthopalladated Complex with 2,2’-Bipyridine 7a

Compound 7a was prepared following the same experimental method as for 6a. Compound 3a (100.0 mg, 0.1 mmol) was reacted with AgClO4 (45.7 mg, 0.2 mmol) and 2,2’-bipyridine (34.4 mg, 0.2 mmol) in 10 mL of a mixture of CH2Cl2/acetone (9/1) to give 7a as a red solid. Obtained: 132.1 mg (93% yield). HRMS (ESI+) [m/z]: calculated for C30H24N3O4Pd 596.0802 [M–ClO4]+; found 596.0795. 1H NMR (300.13 MHz, CDCl3): δ = 8.62 (br, 2H, H2′, H11’, bipy), 8.30 (br, 2H, H5′, H8’, bipy), 8.09 (s, 1H, =CHvinyl), 8.06 (br, 2H, H4′, H9’, bipy), 7.87 (d, J = 15.9 Hz, 1H, =CHolef), 7.57 (br, 2H, H3′, H10’, bipy), 7.44-7.42 (m, 5H, Ho, Hm, Hp, C6H5), 6.70 (d, J = 15.9 Hz, 1H, =CHolef), 6.60 (d, J = 1.8 Hz, 1H, C6H2, H5), 6.29 (d, J = 1.8 Hz, 1H, C6H2, H3), 3.93 (s, 3H, OCH3), 3.88 (s, 3H, OCH3). 13C{1H} NMR (75.47 MHz, CDCl3): δ = 164.16 (s, C2–O, C6H2), 162.96 (s, C=N), 160.68 (s, C4–O, C6H2), 160.30 (s, C=O), 158.39 (2C overlapped, C, C6′, C7’, bipy), 151.86 (s, =C), 151.01 (2C overlapped, CH, C2’, C11′, bipy), 147.39 (s, =CH, Colef), 141.71 (s, CH, C9′, bipy), 139.48 (s, CH, C4′, bipy), 135.70 (s, =CH, Cvinyl), 133.42 (s, Ci, C6H5), 132.64 (s, Cp, C6H5) 129.73 (s, Co, C6H5), 129.14 (s, Cm, C6H5), 125.99 (s, CH, C8′, bipy), 124.75 (2C overlapped, CH, C3′, C10’, bipy), 122.92 (s, CH, C5′, bipy), 120.43 (s, C6-Pd, C6H2), 118.58 (s, C, C1, C6H2), 115.89 (s, CH, C5, C6H2), 110.93 (s, =CH, Colef), 95.90 (s, CH, C3, C6H2), 56.34 (s, OCH3), 56.14 (s, OCH3).

3.10. Synthesis and Characterization of Orthopalladated Complex with 1,10-Phenanthroline 8a

Compound 8a was prepared following the same experimental method as for 6a. Compound 3a (100.0 mg, 0.1 mmol) was reacted with AgClO4 (45.7 mg, 0.2 mmol) and 1,10-phenanthroline mono-hydrate (43.5 mg, 0.2 mmol) in 10 mL of a mixture of CH2Cl2/acetone (9/1) to give 8a as a deep red solid. Obtained: 147.8 mg (95% yield). HRMS (ESI+) [m/z]: calculated for C32H24N3O4Pd 620.0802 [M–ClO4]+; found 620.0834. 1H NMR (300.13 MHz, CD2Cl2): δ = 8.77–8.75 (m, 2H, H2′, H13′, phen), 8.67 (d, J = 7.2 Hz, 1H, H4′, phen), 8.42 (d, J = 7.8 Hz, 1H, H11′, phen), 8.16 (s, 2H, H7′, H8′, phen), 8.14 (s, 1H, =CHvinyl), 8.01–7.92 (m, 1H, =CHolef), 7.78–7.74 (m, 2H, H3′, H12′, phen), 7.55–7.36 (m, 5H, Ho, Hm, Hp, C6H5), 6.90 (d, J = 15.9 Hz, 1H, =CHolef), 6.75 (d, J = 1.8 Hz, 1H, H5, C6H2), 6.39 (d, J = 2.1 Hz, 1H, H3, C6H2), 3.98 (s, 3H, OCH3), 3.95 (s, 3H, OCH3). 13C{1H} NMR (75.47 MHz, CD2Cl2): δ = 164.92 (s, C2–O, C6H2), 163.69 (s, C=N), 161.08 (s, C=O), 161.03 (s, C4–O, C6H2), 157.75 (s, C, C6′, phen), 156.89 (s, C, C10′, phen) 153.06 (s, CH, C2′, phen), 150.24 (s, CH, C13′, phen), 148.09 (s, =CH, Colef), 141.09 (s, CH, C11′, phen), 140.79 (s, CH, C4′, phen), 135.86 (s, =CH, Cvinyl), 134.19 (s, Ci, C6H5), 132.89 (s, CH, Cp, C6H5), 131.19 (s, C, C5′, phen), 131.12 (s, C, C9′, phen), 130.94 (s, =C), 130.02 (s, Co, C6H5), 129.49 (s, Cm, C6H5), 128.45 (2C overlapped, CH, C7′, C8′, phen), 127.77 (s, CH, C3′, phen), 125.99 (s, CH, C12′, phen), 121.23 (s, C6-Pd, C6H2), 119.08 (s, C1, C6H2), 116.43 (s, CH, C5, C6H2), 111.39 (s, =CH, Colef), 95.83 (s, CH, C3, C6H2), 56.74 (s, OCH3), 56.71 (s, OCH3).

4. Conclusions

New oxazolones that are structurally related to the chromophore of the Kaede protein were prepared and orthopalladated selectively at the 4-arylidene ring. Different anionic and neutral ancillary chelating ligands were coordinated to the [Pd(C,N-oxazolone)]+ fragment, with this structural unit showing a higher synthetic versatility than previous examples derived from the chromophore of the GFP. However, the structural characterization by X-ray diffraction of one representative showed that the ligands, mostly the oxazolone, are strongly distorted due to intramolecular repulsions. The fluorescence of these complexes was studied. Overall, the introduction of the Pd atom promotes an increase in the quantum yield of the fluorescence of the oxazolone 1a by up to one order of magnitude (from <1% to 12%). However, other factors must also be considered, such as the push–pull character of the oxazolone, which is modulated by the arylidene substituents (OMe vs. F in this case), and its steric requirements, strongly dependent on the functionality in position 2 of the oxazolone (E-styryl in this case). Therefore, although oxazolones with structures related to the chromophore of the Kaede protein have advantages from the synthetic point of view, they do not provide noticeable improvements in the photophysical properties.

Supplementary Materials

The following are available online. NMR spectra, IR spectra, absorption spectra and excitation–emission spectra. Supplementary Material corresponding to the X-ray structure has been deposited in the CCDC as CCDC-2035173 (see Materials and Methods).

Author Contributions

Conceptualization, E.P.U.; experimental, E.L., D.D., S.A., A.P.; X-ray data acquisition, structure solution and refinement, A.P.; fluorescence analysis, O.C.; writing—original draft preparation, E.P.U.; writing—review and editing, E.P.U., O.C., E.L., C.S.; supervision, E.P.U., C.S.; project administration, A.I.J., C.S.; funding acquisition, E.P.U., A.I.J., C.S. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Aragón Government (Spain, Project LMP144_18: Programa Operativo FEDER Aragón 2014–2020, “Construyendo Europa desde Aragón”, and DGA-FSE research group Aminoácidos y Péptidos E19_20R); the Spanish Government (Project No. PID2019-106394GB-100); the European Cooperation in Science and Technology (COST) program under CA15106 grant (CHAOS: CH Activation in Organic Synthesis); the Romanian Ministry of Education and Research through the grant PN-III-P1-1.1-MC-2018-2580; the Ministerio de Economía y Competitividad (Spain) PID2019-104379RB-C21 and DGA-FSE (E07_20R).

Data Availability Statement

The data presented are available in the published version of the manuscript and Supplementary Materials.

Acknowledgments

The authors express their thanks to the Spanish Government and Romanian Ministry of Education and Research for financial support through the above mentioned research grants.

Conflicts of Interest

The authors declare no conflict of interest.

Sample Availability

Samples of the compounds are not available from the authors.

References

  1. Edgar, A. Luminescent Materials. In Springer Handbook of Electronic and Photonic Materials; Kasap, S., Capper, P., Eds.; Springer Handbooks; Springer Nature: Cham, Switzerland, 2017. [Google Scholar] [CrossRef] [Green Version]
  2. Valeur, B.; Berberan-Santos, M.N. Molecular Fluorescence, Principles and Applications, 2nd ed.; Wiley-VCH: Weinheim, Germany, 2013. [Google Scholar]
  3. Guo, J.; Yu, H.; Cui, T. Applications of fluorescent materials in the detection of alkaline phosphatase activity. J. Biomed. Mater. Res. 2021, 109, 214–226. [Google Scholar] [CrossRef]
  4. Yang, Z.; Sharma, A.; Qi, J.; Peng, X.; Lee, D.Y.; Hu, R.; Lin, D.; Qu, J.; Kim, J.S. Super-resolution fluorescent materials: An insight into design and bioimaging applications. Chem. Soc. Rev. 2016, 45, 4651–4667. [Google Scholar] [CrossRef] [PubMed]
  5. Wang, H.; Ji, X.; Li, Z.; Huang, F. Fluorescent Supramolecular Polymeric Materials. Adv. Mater. 2017, 29, 1606117. [Google Scholar] [CrossRef]
  6. Xiong, H.; Zheng, H.; Wang, W.; Liang, J.; Wen, W.; Zhang, X.; Wang, S. A convenient purification method for silver nanoclusters and its applications in fluorescent pH sensors for bacterial monitoring. Biosens. Bioelectron. 2016, 86, 164–168. [Google Scholar] [CrossRef] [PubMed]
  7. Zhu, M.; Yang, C. Blue fluorescent emitters: Design tactics and applications in organic light-emitting diodes. Chem. Soc. Rev. 2013, 42, 4963–4976. [Google Scholar] [CrossRef]
  8. Shimomura, O. Discovery of Green Fluorescent Protein (GFP) (Nobel Lecture). Angew. Chem. Int. Ed. 2009, 48, 5590–5602. [Google Scholar] [CrossRef]
  9. Chalfie, M. GFP: Lighting Up Life (Nobel Lecture). Angew. Chem. Int. Ed. 2009, 48, 5603–5611. [Google Scholar] [CrossRef] [PubMed]
  10. Tsien, R.Y. Constructing and exploiting the fluorescent protein paintbox (Nobel Lecture). Angew. Chem. Int. Ed. 2009, 48, 5612–5626. [Google Scholar] [CrossRef] [PubMed]
  11. Dedecker, P.; De Schryver, F.C.; Hofkens, J. Fluorescent Proteins: Shine on, You Crazy Diamond. J. Am. Chem. Soc. 2013, 135, 2387–2402. [Google Scholar] [CrossRef] [PubMed]
  12. Rodrigues, C.A.B.; Mariz, I.F.A.; Maçôas, E.M.S.; Afonso, C.A.M. Two-photon absorption properties of push-pull oxazolones derivatives. Dye. Pigment. 2012, 95, 713–722. [Google Scholar] [CrossRef]
  13. Rodrigues, C.A.B.; Mariz, I.F.A.; Maçôas, E.M.S.; Afonso, C.A.M.; Martinho, J.M.G. Unsaturated oxazolones as nonlinear fluorophores. Dye. Pigment. 2013, 99, 642–652. [Google Scholar] [CrossRef]
  14. Icli, S.; Icil, H.; Alp, S.; Koc, H.; McKillop, A. NMR, absorption and fluorescence parameters of azlactones. Spectrosc. Lett. 1994, 27, 1115–1128. [Google Scholar] [CrossRef]
  15. Icli, S.; Doroshenko, A.O.; Alp, S.; Abmanova, N.A.; Egorova, S.I.; Astley, S.T. Structure and Luminescent Properties of the 4-Arylidene-2-Aryl-5-Oxazolones (Azlactones) In Solution and Crystalline State. Spectrosc. Lett. 1999, 32, 553–569. [Google Scholar] [CrossRef]
  16. Smokal, V.; Kolendo, A.; Krupka, O.; Sahraoui, B. Synthesis, photophysical and photochemical properties of oxazolone derivatives. J. Optoelectron. Adv. Mater. 2008, 10, 607–612. [Google Scholar]
  17. Blanco-Lomas, M.; Campos, P.J.; Sampedro, D. Benzylidene-Oxazolones as Molecular Photoswitches. Org. Lett. 2012, 14, 4334–4337. [Google Scholar] [CrossRef] [PubMed]
  18. Blanco-Lomas, M.; Funes-Ardoiz, I.; Campos, P.J.; Sampedro, D. Oxazolone-Based Photoswitches: Synthesis and Properties. Eur. J. Org. Chem. 2013, 6611–6618. [Google Scholar] [CrossRef]
  19. Funes-Ardoiz, I.; Blanco-Lomas, M.; Campos, P.J.; Sampedro, D. Benzylidene-oxazolones as photoswitches: Photochemistry and theoretical calculations. Tetrahedron 2013, 69, 9766–9771. [Google Scholar] [CrossRef]
  20. García-Irepa, C.; Marazzi, M.; Frutos, L.M.; Sampedro, D. E/Z Photochemical switches: synthesis, properties and applications. Rsc Adv. 2013, 3, 6241–6266. [Google Scholar] [CrossRef]
  21. Ertekin, K.; Alp, S.; Karapire, C.; Yenigül, B.; Henden, E.; Içli, S. Fluorescence emission studies of an azlactone derivative embedded in polymer films. An optical sensor for pH measurements. J. Photochem. Photobiol. A Chem. 2000, 137, 155–161. [Google Scholar] [CrossRef]
  22. Acharya, A.; Bogdanov, A.M.; Grigorienko, B.L.; Bravaya, K.B.; Nemukhin, A.V.; Lukyanov, K.A.; Krylov, A.I. Photoinduced Chemistry in Fluorescent Proteins: Curse or Blessing? Chem. Rev. 2017, 117, 758–795. [Google Scholar] [CrossRef]
  23. Gozem, S.; Luk, H.L.; Schapiro, I.; Olivucci, M. Theory and Simulation of the Ultrafast Double-Bond Isomerization of Biological Chromophores. Chem. Rev. 2017, 117, 13502–13565. [Google Scholar] [CrossRef] [Green Version]
  24. Liu, R.S.H. Photoisomerization by hula-twist: A fundamental supramolecular photochemical reaction. Acc. Chem. Res. 2001, 34, 555–562. [Google Scholar] [CrossRef] [PubMed]
  25. Meech, S.R. Excited State Reactions in Fluorescent Proteins. Chem. Soc. Rev. 2009, 38, 2922–2934. [Google Scholar] [CrossRef] [PubMed]
  26. Tolbert, L.M.; Baldridge, A.; Kowalik, J.; Solntsev, K.M. Collapse and Recovery of Green Fluorescent Protein Chromophore Emission through Topological Effects. Acc. Chem. Res. 2012, 45, 171–181. [Google Scholar] [CrossRef] [PubMed]
  27. Follenius-Wund, A.; Bourotte, M.; Schmitt, M.; Iyice, F.; Lami, H.; Bourguignon, J.J.; Haiech, J.; Pigault, C. Fluorescent Derivatives of the GFP Chromophore Give a New Insight into the GFP Fluorescence Process. Biophys. J. 2003, 85, 1839–1850. [Google Scholar] [CrossRef] [Green Version]
  28. Litvinenko, K.L.; Webber, N.M. Meech, S.R. Internal Conversion in the Chromophore of the Green Fluorescent Protein: Temperature dependence and Isoviscosity Analysis. J. Phys. Chem. A 2003, 107, 2616–2623. [Google Scholar] [CrossRef]
  29. Mandal, D.; Tahara, T.; Meech, S.R. Excited-State Dynamics in the Green Fluorescent Protein Chromophore. J. Phys. Chem. B 2004, 108, 1102–1108. [Google Scholar] [CrossRef]
  30. Martin, M.E.; Negri, F.; Olivucci, M. Origin, Nature, and Fate of the Fluorescent State of the Green Fluorescent Protein Chromophore at the CASPT2//CASSCF Resolution. J. Am. Chem. Soc. 2004, 126, 5452–5464. [Google Scholar] [CrossRef] [PubMed]
  31. Andresen, M.; Wahl, M.C.; Stiel, A.C.; Gräter, F.; Schäfer, L.V.; Trowitzsch, S.; Weber, G.; Eggeling, C.; Grubmüller, H.; Hell, S.W.; et al. Structure and mechanism of the reversible photoswitch of a fluorescent protein. Proc. Natl. Acad. Sci. USA 2005, 102, 13070–13074. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  32. Stavrov, S.S.; Solntsev, K.M.; Tolbert, L.M.; Huppert, D. Probing the Decay Coordinate of the Green Fluorescent Protein: Arrest of Cis-Trans Isomerization by the Protein Significantly Narrows the Fluorescence Spectra. J. Am. Chem. Soc. 2006, 128, 1540–1546. [Google Scholar] [CrossRef] [PubMed]
  33. Yang, J.-S.; Huang, G.-J.; Liu, Y.-H.; Peng, S.-M. Photoisomerization of the Green Fluorescence Protein Chromophore and the meta- and para-Amino Analogues. Chem. Commun. 2008, 1344–1346. [Google Scholar] [CrossRef] [PubMed]
  34. Voliani, V.; Bizzarri, R.; Nifosi, R.; Abbruzzetti, S.; Grandi, E.; Viappiani, C.; Beltram, F. Cis-Trans Photoisomerization of Fluorescent-Protein Chromophore. J. Phys. Chem. B 2008, 112, 10714–10722. [Google Scholar] [CrossRef]
  35. Ivashkin, P.E.; Yampolsky, I.V.; Lukyanov, K.A. Synthesis and Properties of Chromophores of Fluorescent Proteins. Russ. J. Bioorg. Chem. 2009, 35, 652–669. [Google Scholar] [CrossRef] [PubMed]
  36. Megley, C.M.; Dickson, L.A.; Maddalo, S.L.; Chandler, G.J.; Zimmer, M. Photophysics and Dihedral Freedom of the Chromophore in Yellow, Blue, and Green Fluorescent Protein. J. Phys. Chem. B 2009, 113, 302–308. [Google Scholar] [CrossRef] [Green Version]
  37. Rajbongshi, B.K.; Sen, P.; Ramanathan, G. Twisted intramolecular charge transfer in a model green fluorescent protein luminophore analog. Chem. Phys. Lett. 2010, 494, 295–300. [Google Scholar] [CrossRef]
  38. Conyard, J.; Kondo, M.; Heisler, I.A.; Jones, G.; Baldridge, A.; Tolbert, L.M.; Solntsev, K.M.; Meech, S.R. Chemically Modulating the Photophysics of the GFP Chromophore. J. Phys. Chem. B 2011, 115, 1571–1577. [Google Scholar] [CrossRef]
  39. Rafiq, S.; Rajbongshi, B.K.; Nair, N.N.; Sen, P.; Ramanathan, G. Excited State Relaxation Dynamics of Model Green Fluorescent Protein Chromophore Analogs: Evidence for Cis−Trans Isomerism. J. Phys. Chem. A 2011, 115, 13733–13742. [Google Scholar] [CrossRef]
  40. Ai, Y.-J.; Liao, R.-Z.; Fang, W.-H.; Luo, Y. Theoretical Studies on the Isomerization Mechanism of the Ortho-Green Fluorescent Protein Chromophore. Phys. Chem. Chem. Phys. 2012, 14, 13409–13414. [Google Scholar] [CrossRef] [PubMed]
  41. Cheng, C.-W.; Huang, G.-J.; Hsu, H.-Y.; Prabhakar, C.; Lee, Y.-P.; Diau, E.W.-G.; Yang, J.-S. Effects of Hydrogen Bonding on Internal Conversion of GFP-like Chromophores. II. The meta-Amino Systems. J. Phys. Chem. B 2013, 117, 2705–2716. [Google Scholar] [CrossRef]
  42. Jiang, M.; He, Z.; Zhang, Y.; Sung, H.H.Y.; Lam, J.W.Y.; Peng, Q.; Yan, Y.; Wong, K.S.; Williams, I.D.; Zhao, Y.; et al. Development of benzylidene-methyloxazolone based AIEgens and decipherment of their working mechanism. J. Mater. Chem. C 2017, 5, 7191–7199. [Google Scholar] [CrossRef]
  43. Conyard, J.; Heisler, I.A.; Chan, Y.; Bulman Page, P.C.; Meech, S.R.; Blancafort, L. A New Twist in the Photophysics of the Gfp Chromophore: A Volume-Conserving Molecular Torsion Couple. Chem. Sci. 2018, 9, 1803–1812. [Google Scholar] [CrossRef] [Green Version]
  44. Taylor, M.A.; Zhu, L.; Rozanov, N.D.; Stout, K.T.; Chen, C.; Fang, C. Delayed Vibrational Modulation of the Solvated Gfp Chromophore into a Conical Intersection. Phys. Chem. Chem. Phys. 2019, 21, 9728–9739. [Google Scholar] [CrossRef] [PubMed]
  45. Chang, J.; Romei, M.G.; Boxer, S.G. Structural Evidence of Photoisomerization Pathways in Fluorescent Proteins. J. Am. Chem. Soc. 2019, 141, 15504–15508. [Google Scholar] [CrossRef] [PubMed]
  46. Chatterjee, T.; Mandal, M.; Gude, V.; Bag, P.P.; Mandal, P.K. Strong electron donation induced differential nonradiative decay pathways for para and meta GFP chromophore analogues. Phys. Chem. Chem. Phys. 2015, 17, 20515–20521. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  47. Wu, L.; Burgess, K. Synthesis of Highly Fluorescent GFP-Chromophore Analogues. J. Am. Chem. Soc. 2008, 130, 4089–4096. [Google Scholar] [CrossRef] [PubMed]
  48. Baldridge, A.; Solntsev, K.M.; Song, C.; Tanioka, T.; Kowalik, J.; Hardcastle, K.; Tolbert, L.M. Inhibition of twisting of a green fluorescent protein-like chromophore by metal complexation. Chem. Commun. 2010, 46, 5686–5688. [Google Scholar] [CrossRef]
  49. Baranov, M.S.; Lukyanov, K.A.; Borissova, A.O.; Shamir, J.; Kosenkov, D.; Slipchenko, L.V.; Tolbert, L.M.; Yampolsky, I.V.; Solntsev, K.M. Conformationally Locked Chromophores as Models of Excited-State Proton Transfer in Fluorescent Proteins. J. Am. Chem. Soc. 2012, 134, 6025–6032. [Google Scholar] [CrossRef] [PubMed]
  50. Hsu, Y.H.; Chen, Y.A.; Tseng, H.W.; Zhang, Z.; Shen, J.Y.; Chuang, W.T.; Lin, T.C.; Lee, C.S.; Hung, W.Y.; Hong, B.C.; et al. Locked ortho- and para-Core Chromophores of Green Fluorescent Protein; Dramatic Emission Enhancement via Structural Constraint. J. Am. Chem. Soc. 2014, 136, 11805–11812. [Google Scholar] [CrossRef] [PubMed]
  51. Baranov, M.S.; Solntsev, K.M.; Baleeva, N.S.; Mishin, A.S.; Lukyanov, S.A.; Lukyanov, K.A.; Yampolsky, I.V. Red-Shifted Fluorescent Aminated Derivatives of a Conformationally Locked GFP Chromophore. Chem. Eur. J. 2014, 20, 13234–13241. [Google Scholar] [CrossRef] [PubMed]
  52. Baleeva, N.S.; Myannik, K.A.; Yampolski, I.V.; Baranov, M.S. Bioinspired Fluorescent Dyes Based on a Conformationally Locked Chromophore of the Fluorescent Protein Kaede. Eur. J. Org. Chem. 2015, 5716–5721. [Google Scholar] [CrossRef]
  53. Liu, X.-Y.; Chang, X.-P.; Xia, S.-H.; Cui, G.; Thiel, W. Excited-State Proton-Transfer-Induced Trapping Enhances the Fluorescence Emission of a Locked GFP Chromophore. J. Chem. Theory Comput. 2016, 12, 753–764. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  54. Baleeva, N.S.; Tsarkova, A.S.; Baranov, M.S. Conformationally Locked Chromophores of CFP and Sirius Protein. Tetrahedron Lett. 2016, 57, 3043–3045. [Google Scholar] [CrossRef]
  55. Deng, H.; Yu, C.; Gong, L.; Zhu, X. Self-Restricted Green Fluorescent Protein Chromophore Analogues: Dramatic Emission Enhancement and Remarkable Solvatofluorochromism. J. Phys. Chem. Lett. 2016, 7, 2935–2944. [Google Scholar] [CrossRef] [PubMed]
  56. Deng, H.; Zhang, Z.; Zhao, Y.; Yu, C.; Gong, L.; Yan, D.; Zhu, X. Self-Restricted oxazolone GFP chromophore for construction of reaction-based fluorescent probe toward dopamine. Mater. Today Chem. 2017, 3, 73–81. [Google Scholar] [CrossRef]
  57. Baleeva, N.S.; Zaitseva, S.O.; Gorbachev, D.A.; Smirnov, A.Y.; Zagudaylova, M.B.; Baranov, M.S. The Role of N-Substituents in Radiationless Deactivation of Aminated Derivatives of a Locked GFP Chromophore. Eur. J. Org. Chem. 2017, 5219–5224. [Google Scholar] [CrossRef]
  58. Chen, C.; Liu, W.; Baranov, M.S.; Baleeva, N.S.; Yampolsky, I.V.; Zhu, L.; Wang, Y.; Shamir, A.; Solntsev, K.M.; Fang, C. Unveiling Structural Motions of a HighlyFluorescent Superphotoacid by Locking and Fluorinating the GFP Chromophore in Solution. J. Phys. Chem. Lett. 2017, 8, 5921–5928. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  59. Chen, C.; Baranov, M.S.; Zhu, L.; Baleeva, N.S.; Smirnov, A.Y.; Zaitseva, S.O.; Yampolsky, I.V.; Solntsev, K.M.; Fang, C. Designing redder and brighter fluorophores by synergistic tuning of ground and excited states. Chem. Commun. 2019, 55, 2537–2540. [Google Scholar] [CrossRef] [PubMed]
  60. Chen, C.; Zhu, L.; Baranov, M.S.; Tang, L.; Baleeva, N.S.; Smirnov, A.Y.; Yampolsky, I.V.; Solntsev, K.M.; Fang, C. Photoinduced Proton Transfer of GFP-Inspired Fluorescent Superphotoacids: Principles and Design. J. Phys. Chem. B 2019, 123, 3804–3821. [Google Scholar] [CrossRef]
  61. Lin, C.Y.; Romei, M.G.; Oltrogge, L.M.; Mathews, I.I.; Boxer, S.G. Unified Model for Photophysical and Electro-Optical Properties of Green Fluorescent Proteins. J. Am. Chem. Soc. 2019, 141, 15250–15265. [Google Scholar] [CrossRef] [PubMed]
  62. Chatterjee, S.; Ahire, K.; Karuso, P. Room Temperature Dual Fluorescence of a Locked GFP Chromophore Analogue. J. Am. Chem. Soc. 2020, 142, 738–749. [Google Scholar] [CrossRef] [PubMed]
  63. Collado, S.; Pueyo, A.; Baudequin, C.; Bischoff, L.; Jiménez, A.I.; Cativiela, C.; Hourau, C.; Urriolabeitia, E.P. Orthopalladation of GFP-Like Fluorophores Through C–H Bond Activation: Scope and Photophysical Properties. Eur. J. Org. Chem. 2018, 6158–6166. [Google Scholar] [CrossRef]
  64. Roiban, D.; Serrano, E.; Soler, T.; Grosu, I.; Cativiela, C.; Urriolabeitia, E.P. Unexpected [2 + 2] C–C bond coupling due to photocycloaddition on orthopalladated (Z)-2-aryl-4-arylidene-5(4H)-oxazolones. Chem. Commun. 2009, 4681–4683. [Google Scholar] [CrossRef]
  65. Roiban, G.D.; Serrano, E.; Soler, T.; Aullón, G.; Grosu, I.; Cativiela, C.; Martínez, M.; Urriolabeitia, E.P. Regioselective Orthopalladation of (Z)-2-Aryl-4-Arylidene-5(4H)-Oxazolones: Scope, Kinetico-Mechanistic, and Density Functional Theory Studies of the C–H Bond Activation. Inorg. Chem. 2011, 50, 8132–8143. [Google Scholar] [CrossRef]
  66. Serrano, E.; Juan, A.; García-Montero, A.; Soler, T.; Jiménez-Márquez, F.; Cativiela, C.; Gomez, M.V.; Urriolabeitia, E.P. Stereoselective Synthesis of 1,3-Diaminotruxillic Acid Derivatives: An Advantageous Combination of C–H–ortho–Palladation and On-Flow [2+2]–Photocycloaddition in Microreactors. Chem. Eur. J. 2016, 22, 144–152. [Google Scholar] [CrossRef] [Green Version]
  67. Carrera, C.; Denisi, A.; Cativiela, C.; Urriolabeitia, E.P. Functionalized 1,3-Diaminotruxillic Acids by Pd-Mediated C–H Activation and [2+2]–Photocycloaddition of 5(4H)–Oxazolones. Eur. J. Inorg. Chem. 2019, 3481–3489. [Google Scholar] [CrossRef]
  68. Urriolabeitia, E.P.; Sánchez, P.; Pop, A.; Silvestru, C.; Laga, E.; Jiménez, A.I.; Cativiela, C. Synthesis of esters of diaminotruxillic bis-amino acids by Pd-mediated photocycloaddition of analogs of the Kaede protein chromophore. Beilstein J. Org. Chem. 2020, 16, 1111–1123. [Google Scholar] [CrossRef] [PubMed]
  69. Roiban, G.D.; Serrano, E.; Soler, T.; Contel, M.; Grosu, I.; Cativiela, C.; Urriolabeitia, E.P. Ortho-Palladation of (Z)-2-Aryl-4-Arylidene-5(4H)-Oxazolones. Structure and Functionalization. Organometallics 2010, 29, 1428–1435. [Google Scholar] [CrossRef]
  70. Miyawaki, A. Proteins on the move: Insights gained from fluorescent protein technologies. Nat. Rev. Mol. Cell Biol. 2011, 12, 656–668. [Google Scholar] [CrossRef] [PubMed]
  71. Ando, R.; Hama, H.; Yamamoto-Hino, M.; Mizuno, H.; Miyawaki, A. An optical marker based on the UV-induced green-to-red photoconversion of a fluorescent protein. Proc. Natl. Acad. Sci. USA 2002, 99, 12651–12656. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  72. Patterson, G.H.; Lippincott-Schwartz, J. A Photoactivatable GFP for Selective Photolabeling of Proteins and Cells. Science 2002, 297, 1873–1877. [Google Scholar] [CrossRef]
  73. Plöchl, J. Ueber Phenylglycidasäure (Phenyloxacrylsäure). Chem. Ber. 1883, 16, 2815. [Google Scholar] [CrossRef] [Green Version]
  74. Plöchl, J. Ueber einige Derivate der Benzoylimidozimmtsäure. Chem. Ber. 1884, 17, 1616. [Google Scholar] [CrossRef] [Green Version]
  75. Erlenmeyer, E. Ueber die Condensation der Hippursäure mit Phtalsäureanhydrid und mit Benzaldehyd. Justus Liebigs Ann. Der Chem. 1893, 275, 1–8. [Google Scholar]
  76. Carter, H.E. Azlactones. Org. React. 1946, 3, 198–237. [Google Scholar]
  77. Filler, R. Advances in Heterocyclic Chemistry; Katritzky, A.R., Ed.; Academic Press: New York, NY, USA, 1954; Chapter 4; p. 75. [Google Scholar]
  78. Rao, Y.S.; Filler, R. Geometric Isomers of 2-Aryl(Aralkyl)-4-arylidene(alkylidene)-5(4H)-oxazolones. Synthesis 1975, 12, 749–764. [Google Scholar] [CrossRef]
  79. Rao, Y.S.; Filler, R. Oxazoles. In The Chemistry of Heterocyclic Compounds, Volume 45; Turchi, I.J., Ed.; John Wiley & Sons, Inc.: New York, NY, USA, 1986; Chapter 3; pp. 363–691. [Google Scholar]
  80. Kim, Y.; Ko, Y.H.; Jung, M.; Selvapalam, N.; Kim, K. A new photo-switchable “on-off” host–guest system. Photochem. Photobiol. Sci. 2011, 10, 1415–1419. [Google Scholar] [CrossRef] [PubMed]
  81. Prokofev, E.P.; Karpeiskaya, E.I. The proton coupled 13C NMR direct determination of Z-,E-configuration of 4-benzyliden-2-phenyl(methyl)-Δ2-oxazolin-5-ones and products of their solvolysis. Tetrahedron Lett. 1979, 20, 737–740. [Google Scholar] [CrossRef]
  82. Vana, J.; Lang, J.; Soltesova, M.; Hanusek, J.; Ruzicka, A.; Sedlak, M.; Roithova, J. The role of trinuclear species in a palladium acetate/trifluoroacetic acid catalytic system. Dalton Trans. 2017, 46, 16269–16275. [Google Scholar] [CrossRef] [Green Version]
  83. Vana, J.; Hanusek, J.; Sedlak, M. Bi and trinuclear complexes in palladium carboxylate-assisted C–H activation reactions. Dalton Trans. 2018, 47, 1378–1382. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  84. Nakamoto, K. Infrared and Raman Spectra of Inorganic and Coordination Compounds, 5th ed.; John Wiley: New York, NY, USA, 1997. [Google Scholar]
  85. Guy Orpen, A.; Brammer, L.; Allen, F.H.; Kennard, O.; Watson, D.G.; Taylor, R. Supplement. Tables of bond lengths determined by X-ray and neutron diffraction. Part 2. Organometallic compounds and co-ordination complexes of the d- and f-block metals. J. Chem. Soc. Dalton Trans. 1989, S1–S83. [Google Scholar] [CrossRef]
  86. SAINT, Version 5.0 ed.; Bruker Analytical X-Ray Systems: Madison, WI, USA, 1998.
  87. Sheldrick, G.M. SADABS, Program for Absorption and Other Corrections; Göttingen University: Göttingen, Germany, 1996. [Google Scholar]
  88. Sheldrick, G.M. SHELXT—Integrated Space-Group and Crystal- Structure Determination. Acta Crystallogr. Sect. A Found. Adv. 2015, A71, 3–8. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  89. Sheldrick, G.M. Crystal structure refinement with SHELXL. Acta Crystallogr. Sect. C Struct. Chem. 2015, C71, 3–8. [Google Scholar] [CrossRef] [PubMed]
  90. Farrugia, L.J. WinGX and ORTEP for Windows: An update. J. Appl. Crystallogr. 2012, 45, 849–854. [Google Scholar] [CrossRef]
Molecules 26 01238 g001 550
Figure 1. Schematic structures of 4-arylidene-5(4H)-imidazolones (a) and -oxazolones (b).
Figure 1. Schematic structures of 4-arylidene-5(4H)-imidazolones (a) and -oxazolones (b).
Molecules 26 01238 g001
Molecules 26 01238 g002 550
Figure 2. Different strategies in order to avoid non-radiative loss of fluorescence: self-restriction and molecular locks to constrain twisting internal motions.
Figure 2. Different strategies in order to avoid non-radiative loss of fluorescence: self-restriction and molecular locks to constrain twisting internal motions.
Molecules 26 01238 g002
Molecules 26 01238 g003 550
Figure 3. Previous work on the Pd-locked green fluorescent protein (GFP) chromophore, showing limited reactivity; comparison with the present work with the Kaede protein, showing a more general scope of reactivity.
Figure 3. Previous work on the Pd-locked green fluorescent protein (GFP) chromophore, showing limited reactivity; comparison with the present work with the Kaede protein, showing a more general scope of reactivity.
Molecules 26 01238 g003
Molecules 26 01238 sch001 550
Scheme 1. Synthesis of starting oxazolones 1a and 1b.
Scheme 1. Synthesis of starting oxazolones 1a and 1b.
Molecules 26 01238 sch001
Molecules 26 01238 g004 550
Figure 4. Molecular drawing of oxazolone 1a.
Figure 4. Molecular drawing of oxazolone 1a.
Molecules 26 01238 g004
Molecules 26 01238 sch002 550
Scheme 2. Orthopalladation of oxazolone 1a and reactivity of orthometalated derivative 2a: synthesis of oxazolone derivative 3a.
Scheme 2. Orthopalladation of oxazolone 1a and reactivity of orthometalated derivative 2a: synthesis of oxazolone derivative 3a.
Molecules 26 01238 sch002
Molecules 26 01238 sch003 550
Scheme 3. Orthopalladation of oxazolone 1b.
Scheme 3. Orthopalladation of oxazolone 1b.
Molecules 26 01238 sch003
Molecules 26 01238 sch004 550
Scheme 4. Reactivity of 3a to give orthopalladated derivatives 4a–8a.
Scheme 4. Reactivity of 3a to give orthopalladated derivatives 4a–8a.
Molecules 26 01238 sch004
Molecules 26 01238 sch005 550
Scheme 5. Reactivity of 2b to give orthopalladated derivatives 3b and 4b.
Scheme 5. Reactivity of 2b to give orthopalladated derivatives 3b and 4b.
Molecules 26 01238 sch005
Molecules 26 01238 g005 550
Figure 5. Molecular drawing of complex 7a.
Figure 5. Molecular drawing of complex 7a.
Molecules 26 01238 g005
Molecules 26 01238 g006 550
Figure 6. Molecular drawing of complex 7a, showing the distortion of the oxazolone fragment.
Figure 6. Molecular drawing of complex 7a, showing the distortion of the oxazolone fragment.
Molecules 26 01238 g006
Molecules 26 01238 g007 550
Figure 7. Normalized excitation–emission spectrum of (a) 1a; (b) 1b.
Figure 7. Normalized excitation–emission spectrum of (a) 1a; (b) 1b.
Molecules 26 01238 g007
Table
Table 1. Selected bond distances (Å) and angles (°) for 7a.
Table 1. Selected bond distances (Å) and angles (°) for 7a.
Pd(1)-N(1)2.060(3)N(1)-Pd(1)-N(3)173.70(12)
Pd(1)-N(2)2.110(3)N(1)-Pd(1)-C(1)98.62(13)
Pd(1)-N(3)2.006(3)N(2)-Pd(1)-N(3)96.35(11)
Pd(1)-C(1)2.013(3)N(2)-Pd(1)-C(1)177.06(12)
N(1)-Pd(1)-N(2)78.55(11)N(3)-Pd(1)-C(1)86.53(12)
Table
Table 2. Absorption maxima for compounds 1a, 4a, 6a, 7a, 8a, 1b and 4b. 1
Table 2. Absorption maxima for compounds 1a, 4a, 6a, 7a, 8a, 1b and 4b. 1
Compoundλabs,max (nm)Compoundλabs,max (nm)
1a4281b381
4a4684b446
6a490
7a4958a494
1 Values in CH2Cl2 solution at 25 °C, concentration 5 × 10−4 M.
Table
Table 3. Excitation–emission maxima, counts for compounds 1a, 4a, 6a, 7a, 8a, 1b and 4b and quantum yields for 1a and 6a 1
Table 3. Excitation–emission maxima, counts for compounds 1a, 4a, 6a, 7a, 8a, 1b and 4b and quantum yields for 1a and 6a 1
Compoundλexc,max (nm)λemis,max (nm)CountsQY
1a480, 3315052.7 × 104<1%
1b420, 326534, 493, 462, 4372.4 × 104
4a516, 480, 446476, 4531 × 106-
4b480, 321569 (h), 5253.6 × 104-
6a539, 469, 3715895 × 10612% 2
7a555, 433, 3905993 × 106-
8a529, 4125641.6 × 105-
1 Values in CH2Cl2 solution at 25 °C, concentration 5 × 10−4 M. 2 Concentration 10−5 M (λexc = 490 nm).
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Laga, E.; Dalmau, D.; Arregui, S.; Crespo, O.; Jimenez, A.I.; Pop, A.; Silvestru, C.; Urriolabeitia, E.P. Fluorescent Orthopalladated Complexes of 4-Aryliden-5(4H)-oxazolones from the Kaede Protein: Synthesis and Characterization. Molecules 2021, 26, 1238. https://doi.org/10.3390/molecules26051238

AMA Style

Laga E, Dalmau D, Arregui S, Crespo O, Jimenez AI, Pop A, Silvestru C, Urriolabeitia EP. Fluorescent Orthopalladated Complexes of 4-Aryliden-5(4H)-oxazolones from the Kaede Protein: Synthesis and Characterization. Molecules. 2021; 26(5):1238. https://doi.org/10.3390/molecules26051238

Chicago/Turabian Style

Laga, Eduardo, David Dalmau, Sofía Arregui, Olga Crespo, Ana I. Jimenez, Alexandra Pop, Cristian Silvestru, and Esteban P. Urriolabeitia. 2021. "Fluorescent Orthopalladated Complexes of 4-Aryliden-5(4H)-oxazolones from the Kaede Protein: Synthesis and Characterization" Molecules 26, no. 5: 1238. https://doi.org/10.3390/molecules26051238

APA Style

Laga, E., Dalmau, D., Arregui, S., Crespo, O., Jimenez, A. I., Pop, A., Silvestru, C., & Urriolabeitia, E. P. (2021). Fluorescent Orthopalladated Complexes of 4-Aryliden-5(4H)-oxazolones from the Kaede Protein: Synthesis and Characterization. Molecules, 26(5), 1238. https://doi.org/10.3390/molecules26051238

Article Metrics

Back to TopTop